Form 4: Conmed Corp VP Global Manufacturing Reports Transaction in Company Stock

Edward A. Clifford, VP Global Manufacturing at Conmed Corp, reports the settlement of vested restricted stock units and subsequent disposition of shares to cover taxes.

Summary

• On August 1, 2024, Edward A. Clifford, VP Global Manufacturing at Conmed Corp, reported a transaction involving the company's stock.
• 500 shares of common stock were acquired through the settlement of vested restricted stock units (RSUs).
• Simultaneously, 122 shares were disposed of to cover tax obligations at a price of $65.34 per share.
• Following these transactions, Clifford directly owns 378 shares of Conmed Corp common stock and 1,500 RSUs.

Sentiment

Score: 5

Explanation: This is a neutral document reflecting standard insider trading activity related to equity compensation. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This is a routine disclosure of insider transactions, which is common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in compliance with SEC regulations.
• The vesting schedule of the RSUs (25% over four years) is a common vesting structure.
• Tax withholding via share disposition is a typical method for handling taxes related to equity compensation.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates